NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
89 percent of cancer centers report that cancer drugs are in short supply, most often vinblastine, etoposide, and topotecan
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.